跳至主要内容
临床试验/KCT0003515
KCT0003515已完成未知

To evaluate the clinical and radiological results of biodegradable calcium phosphate bone cement for the augmentation of internally-fixed unstable trochanteric fracture using intramedullary nail

Kangdong Sacred Heart Hospital0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
65(Year) 至 o Limit(—)
性别
All

入选标准

  • The trial included patients with unstable trochanteric (three or four parts fractures, AO type A2, Evans unstable Type 1). Additional inclusion criteria were as follows: age more than 65 years, walking with or without support, less than 72 hours between the fracture and surgery, and signed informed consent.

排除标准

  • 1) stable two parts factures (AO type A1, Evans stable Type 1);
  • 2) transtrochanteric fractures with a transverse of reversed/oblique fracture line at the level of the lesser trochanter (AO type A3, Evans Type 2)
  • 3) pathological fractures related to tumors and subtrochanteric fractures;
  • 4) tip-apex distance (TAD) > 18 mm
  • 5) limited ability to perform objective functional tests (dementia, serious concomitant illness or mental instability, or neurosensory, neuromuscular or musculoskeletal deficiency
  • 6) soft-tissue infection at the operation site
  • 7) concurrent fractures that would affect the post-operative functional outcome.

研究者

相似试验